Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB

Treatment with nucleos(t)ide analogues (NAs) may be stopped after 1‐3 years of hepatitis B virus DNA suppression in hepatitis B e antigen (HBeAg)‐negative patients according to Asian Pacific Association for the Study of Liver and European Association for the Study of Liver guidelines. However, virol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wübbolding, Maximilian, Lopez Alfonso, Juan Carlos, Lin, Chun‐Yen, Binder, Sebastian, Falk, Christine, Debarry, Jennifer, Gineste, Paul, Kraft, Anke R.M., Chien, Rong‐Nan, Maasoumy, Benjamin, Wedemeyer, Heiner, Jeng, Wen‐Juei, Meyer Hermann, Michael, Cornberg, Markus, Höner zu Siederdissen, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789842/
https://www.ncbi.nlm.nih.gov/pubmed/33437904
http://dx.doi.org/10.1002/hep4.1626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789842/
https://www.ncbi.nlm.nih.gov/pubmed/33437904
http://dx.doi.org/10.1002/hep4.1626

Ejemplares similares